Navigation Links
Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
Date:3/1/2012

SAN DIEGO, March 1, 2012 /PRNewswire/ -- Receptos Inc. today announced that the company is scheduled to present at the Cowen and Company 32nd Annual Health Care Conference at noon EST on Wednesday, March 7, 2012, at the Boston Marriott Copley Place in Boston, Massachusetts. Faheem Hasnain, president and chief executive officer, will provide an overview of the company and an update about its clinical development programs.

"This is an exciting time at Receptos as we move forward with plans to initiate multiple Phase 2 clinical trials later this year and to close our Series B financing round," Hasnain said. "This presentation at the Cowen and Company Health Care Conference gives us the opportunity to provide an update about these initiatives, as well as other areas of focus for Receptos."

About RPC1063 and S1P1 Agonists
RPC1063, developed in the labs of Receptos, is a novel, highly selective S1P1 agonist exhibiting picomolar potency that is effective in rodent models of multiple sclerosis, and possesses an excellent safety profile in non-clinical toxicology studies. In addition to selectivity, which reduces the likelihood of "off-target" side effects, RPC1063 has an appropriately short half-life to promote rapid reversibility of lymphopenia. S1P1 is a G protein-coupled receptor (GPCR) that binds the lipid signaling molecule sphingosine 1-phosphate (S1P). S1P is a circulating lipid that binds to five GPCRs termed S1P1-5. S1P1 selectively regulates physiological functions in the immune and cardiovascular systems, including immune cell trafficking and the maintenance of endothelial integrity. In the disease state of multiple sclerosis, S1P1 agonism works by selectively sequestering circulating lymphocytes, blunting the underlying autoimmune cause of multiple sclerosis.

About Receptos
Receptos is a biopharmaceutical company developing autoimmune therapeutic candidates through information‐driven drug discovery, inclu
'/>"/>

SOURCE Receptos Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Receptos Scientists Publish Determination of a High Resolution Sphingosine 1-Phosphate Receptor 1 Structure in Science
2. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
3. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
5. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
6. Regeneron Announces March 2012 Investor Conference Presentations
7. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
8. OncoSec to Present at 10th Annual BioPartnering North America
9. Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
10. Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
11. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Research and Markets has announced ... & Paper Industry Report 2014" report to their ... & Paper Industry Report 2014 is a professional and ... enzyme for pulp & paper industry. The ... definitions, classifications, applications and industry chain structure. The enzyme ...
(Date:8/27/2014)...  ARCH Venture Partners, one of the largest ... of seed and early-stage advanced technology companies, today ... more than $400 million in subscriptions. ARCH Venture ... by more than $150 million. "The ... potential of our approach to finding and funding ...
(Date:8/27/2014)... 27, 2014 Riviera Beach, Florida ... the creation of the Sancilio Scientific Advisory Board ... SCI’s philosophy of looking to nature for pharmaceutical ... actions are based on sound scientific data, analyses, ... Board provides a vehicle for SCI to receive ...
(Date:8/27/2014)... August 27, 2014 After the boom ... that the next beverage craze is going to be ... that formulators can use Stress Relief energy pattern which ... the making of a beverage, including minerals, herbs and ... energy, channeling that power into rapid recovery and helping ...
Breaking Biology Technology:Global Enzyme for Pulp & Paper Industry Report 2014 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4
... 15 Senetek PLC,(OTC Bulletin Board: SNKTY), a Life ... the science of healthy aging, today,announced an agreement with ... Sciences in Poznan, Poland for the exclusive rights to ... therapeutic technology for,the potential use against a broad range ...
... 15 bwin, the world,s,leading online gaming company, and ... Harvard Medical School Teaching Affiliate, have,just signed an agreement ... to use scientific evidence to create the safest,possible online ... longitudinal study. , ...
... ProGenTech Limited was a winner of the Red Herring 100 Award, ... Asia. , The Red Herring ... top 100 out of more than 1,000,closely evaluated companies that are ... "It is truly an honor to be recognized by ...
Cached Biology Technology:Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology 2bwin and Harvard Medical School Faculty Sign 5-Year Research Cooperation Agreement 2Red Herring Awards ProGenTech Limited for the 2008 Red Herring Asia 100 2
(Date:8/27/2014)... SALT LAKE CITY, Aug. 27, 2014 University of ... in his native Turkey, has won that nation,s highest ... Medal of Science. , Sekercioglu is among five researchers ... Scientific and Technical Research Council of Turkey. Three researchers ... won the Special Award, which is equivalent to ...
(Date:8/27/2014)... The pathogens posing the greatest risk to Europe based ... University of Liverpool researchers using a ,big data, approach ... Institute of Infection and Global Health ranked the top ... domestic animals using a system which, they believe, will ... with the spread of infectious diseases, including as a ...
(Date:8/27/2014)... 2014 /PRNewswire-iReach/ -- The IEEE Engineering in Medicine and ... Annual International Conference (EMBC,14), this year being held at ... Chicago, Illinois , from Tuesday, August 26 through ... and industry professionals in science, medicine, and engineering are ... This year,s conference theme is ...
Breaking Biology News(10 mins):University of Utah biologist wins Turkey's top science prize 2Big data approach identifies Europe's most dangerous human and domestic animal pathogens 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3
... Sam Safran, a professor at the Weizmann Institute in Israel, ... - Pierre-Gilles De Gennes Lecture Prize. The prize, accompanied by ... E (EPJE). Safran is the author of numerous articles ... Lecture Prize, which was named after the Nobel laureate who ...
... The WHO Fracture Risk Assessment Tool (FRAX) has ... country models and accessible in six additional languages. ... http://www.shef.ac.uk/FRAX/ ) that has been developed by the World ... the University of Sheffield, UK. A growing number of ...
... DURHAM, N.C.A personalized approach to smoking cessation therapy is ... Medical Center and the National Institute on Drug Abuse ... makeup with his or her smoking habits can accurately ... "Within three to five years, it,s conceivable we,ll have ...
Cached Biology News:Announcing launch of FRAX version 3.1 2Personalized approach to smoking cessation may be reality in 3-5 years 2Personalized approach to smoking cessation may be reality in 3-5 years 3
... be upgraded to the GenePix Autoloader 4200AL. ... and saves results for up to 36 ... the batch is complete. Line-by-line autofocus ensures ... GenePix Pro gives you complete flexibility to ...
... Maximize the value of your microarray data ... support you need from consultation to extensive ... date methods. Utilize our expertise in combination ... from your own microarray experiments., ,Normalization and ...
... the value of your microarray data ... the support you need from consultation ... most up to date methods. Utilize ... Gene Expression Profiling Service or from ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
Biology Products: